In recent years, studies have shown that the activation of GRP/GRPR pathway plays an important role in the occurrence of prostate cancer [25], suggests that the GRP receptor may be not only a marker, but potentially also a driver of prostatic carcinogenesis, where its over-expression would represent an early event. The gene discussed is GRPR; the disease is prostate carcinoma.